Merck’s colorectal cancer therapy fails late-stage trial
Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
skin cancer
Merck discontinues Phase 3 KeyVibe-010 trial
The trial was discontinued after results showed that the coformulation of vibostolimab and pembrolizumab for treatment of resected…
Merck, Eisai to discontinue late-stage study for skin cancer
Improvement in overall survival was one of the study's dual main goals, according to Merck and Eisai
University of East Anglia researchers make a breakthrough for ‘next gen’ cancer treatment
The treatment would work by switching on LED lights embedded close to a tumour, which would then activate biotherapeutic drugs
Wellcome Trust/DBT India Alliance confers award to promote research on pigmentary disorders
Dr Rajender K Motiani, Assistant Professor at Faridabad-based Regional Centre for Biotechnology receives Rs 3.6 crore grant to…